Barve, Shirish S
- Vanderbilt University Medical Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,756
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#2,756
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Barve, Shirish S as a PI. Multi-PI records show the full award amount for context.
- 5P01AA029542-03P01Contact PIMicrobiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1.7Maward amount
- 3P01AA029542-03S1P01Contact PIMicrobiome, Metabolites, and Alcohol in HIV to Reduce CVD (Supplement)$435.5Kaward amount
- 3P01AA029542-02S1P01Contact PIMicrobiome, Metabolites, and Alcohol in HIV to Reduce CVD (Supplement)$215.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Barve, Shirish S as a PI.
FY2023 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardVanderbilt University Medical Center
- 2004$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011Program/Center Grant Leader
- 2021$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #2899
- 2021Entered Top 25% NationallyRanked #2899
- 2023$10M Cumulative Funding